PRDM7: A Protein with Potential as A Drug Target and Biomarker

Target Name: PRDM7

NCBI ID: G11105

PRDM7

PRDM7: A Protein with Potential as A Drug Target and Biomarker

PRDM7, also known as PR domain zinc finger protein 7, is a protein that is expressed in a variety of tissues and cells throughout the body. It is a non-coding RNA molecule that contains 294 amino acid residues. PRDM7 is known for its role in the regulation of gene expression and has been shown to play a role in a variety of biological processes, including cell growth, differentiation, and inflammation.

One of the most promising aspects of PRDM7 is its potential as a drug target. PRDM7 has been shown to interact with a variety of small molecules, including drugs that are currently being used to treat a variety of diseases. Additionally, PRDM7 has been shown to play a role in the regulation of cellular signaling pathways, which are involved in a wide range of biological processes, including cell growth, differentiation, and inflammation.

PRDM7 has also been shown to be involved in the regulation of stem cell proliferation and the immune response. stem cells are a type of cell that have the ability to develop into any type of cell in the body, and they play a key role in the development and treatment of a variety of diseases. PRDM7 has been shown to regulate the stem cell proliferation and differentiate into different cell types, which could have important implications for the development of cancer therapies.

In addition to its potential as a drug target, PRDM7 also has potential as a biomarker. The expression of PRDM7 has been shown to be associated with a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Additionally, PRDM7 has been shown to have potential as a diagnostic biomarker, as its expression levels can be increased in response to certain diseases or conditions.

Overall, PRDM7 is a protein that has a wide range of potential applications in medicine and research. Its ability to interact with small molecules and its role in the regulation of cellular signaling pathways make it an attractive target for drug development. Additionally, its potential as a biomarker and its involvement in the regulation of stem cell proliferation and the immune response make it a valuable tool for the development of new therapies. Further research is needed to fully understand the role of PRDM7 in these processes and its potential as a drug and biomarker.

Protein Name: PR/SET Domain 7

Functions: Histone methyltransferase that selectively methylates 'Lys-4' of dimethylated histone H3 (H3K4me2) to produce trimethylated 'Lys-4' histone H3 (H3K4me3). May play a role in epigenetic regulation of gene expression by defining an active chromatin state

The "PRDM7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PRDM7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets